Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDry skin isn't listed among Wegovy's most common side effects, but some people using semaglutide do notice their skin feels drier than usual, particularly in the first few months of treatment. The most likely explanation isn't a direct drug effect on skin cells — it's dehydration. Nausea, reduced appetite and higher fluid loss from GI side effects can quietly reduce how much water you're taking in each day, and skin is often one of the first places that shows. These medicines are prescription-only, and any persistent or worsening skin changes are worth discussing with your prescriber rather than managing alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The NHS semaglutide medicines page lists the common side effects of Wegovy: nausea, vomiting, diarrhoea, constipation, stomach pain and headache are the headline items. Dry skin as a standalone effect doesn't appear in those lists. So if you're asking whether semaglutide chemically dries out your skin, the honest answer is: there's no strong evidence it does.
What it does do, consistently, is suppress appetite and slow gastric emptying. Both effects can dampen thirst signals. Add in episodes of nausea or loose stools (especially around dose increases) and many people end up drinking less fluid without realising it. Mild, chronic dehydration is one of the most ordinary causes of dry, flaky or tight-feeling skin. That's the chain worth understanding.
For a fuller picture of how semaglutide relates to skin dryness, you can also read more about semaglutide itself, including how it works and what to expect from treatment. The short version is: the medicine changes your relationship with hunger and thirst, and skin often bears witness to both.
Injection-site reactions (redness, bruising, itching or a small lump at the injection point) are documented, and they're worth distinguishing from generalised dry skin. Rotating injection sites (abdomen, thigh, upper arm) each week significantly reduces them.
There's also a small but real signal around allergic reactions. Itching away from the injection site, hives or swelling can indicate a hypersensitivity response; swelling of the face, lips, tongue or throat needs emergency medical attention. These are rare but serious.
A skin rash from Wegovy can take several forms, and understanding which kind you're looking at matters. A mild, localised reaction at the injection point is very different from a widespread rash that appears days after a dose. If you're unsure which you're dealing with, contact your prescriber or, if you think it may be allergic, seek same-day medical review.
People also sometimes notice changes in skin texture over time on GLP-1 treatment, related to rapid weight loss rather than the drug itself. Losing body weight relatively quickly can affect skin elasticity, a topic that is covered separately here.
The practical steps are mostly about fluid and routine. Aim to drink water consistently through the day rather than relying on thirst to prompt you, because, as above, semaglutide can blunt that prompt. A simple habit that works for many people: keep a water bottle next to your Wegovy pen in the fridge door, so the daily reminder is already built in.
Beyond hydration, a fragrance-free moisturiser applied to damp skin after showering tends to work better than applying it dry. Shorter, cooler showers, swapping heavily fragranced soaps for gentle alternatives, and keeping indoor air humid in winter all help.
If dry skin is bothering you on treatment, mention it at your next clinical review. Your prescriber may want to confirm you're tolerating your current dose well, rule out other contributors and advise on anything specific to your situation. Concerns about whether Wegovy is drying out your skin are a regular part of aftercare conversations, you're not the first to raise it.
Most dry skin during Wegovy treatment is manageable and temporary. But there are situations where the skin change is telling you something more important.
Get same-day medical help if you notice: a rapidly spreading rash, hives, or skin that blisters or peels; swelling around the face or throat; difficulty breathing or swallowing alongside a skin change; or severe stomach pain radiating to the back, which (while not a skin symptom) is the signature warning for pancreatitis flagged in the MHRA's January 2026 Drug Safety Update for GLP-1 medicines.
The MHRA Yellow Card scheme lets you report any suspected side effect from semaglutide, including unexpected skin reactions. You don't need to wait for certainty, a suspicion is enough to make a report, and the data helps regulators track real-world signals that trials can miss.
For context on what Wegovy users commonly report about their skin, the pattern is broadly consistent: mild dryness, usually tied to dehydration and GI settling, that improves as the body adjusts to the dose. Most people don't find it a reason to stop.
If you have questions about starting semaglutide treatment or want clinical input on side effects you're experiencing, you can start a free consultation with our prescribers, who review every case personally on the same day it's submitted.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.